Peter Butch focuses his practice in all fields of intellectual property law, with particular emphasis in procuring domestic and international patents on developments involving complex organic and inorganic chemistry, including pharmaceutical and biotechnology developments. Peter also has experience in preparing infringement and validity opinions, and negotiating and drafting license agreements. He has prepared and prosecuted a number of patent applications on developments relating to pharmaceuticals; semiconductor fabrication; bioinformatics; 3-D nerve tissue MRI methods; biodegradable glycol ether dry-cleaning products; biocompatible polymers; non-linear optical materials; surgical lighting; fluorescent nanoparticles; poly (alkylene oxide) and polyquaternary derivatives; transdermal drug delivery devices; pegylated polypeptides; and rechargeable lithium batteries. Shahnam Sharareh is a registered patent attorney who advises global pharmaceutical, agricultural, and other life science and technology companies on all aspects of patent portfolio development, analysis and appeals, as well as post-grant proceedings and intellectual property transactional activities. He has prepared and prosecuted more than 1,000 U.S. and international patent applications and, as a former patent examiner, provides customized approaches to his clients in a wide range of technologies, including chemistry, pharmaceuticals, pharmacology, biotechnology, medical diagnostics and cosmetic products. As a Regulatory Affairs Certified (RAC) professional, Shahnam utilizes a strong understanding of the regulatory framework of cannabis and hemp-derived CBD products to advise clients on FDA regulatory matters, marketing and advertising strategies for drug and dietary supplement products.